News

Quest Diagnostics, a provider of diagnostic testing, information and services, has reported that its Focus Diagnostics infectious disease reference laboratory has introduced a laboratory-developed real-time polymerase chain reaction

US-based pharmaceutical company Dara BioSciences has reported positive results from a Phase IIa clinical trial of KRN5500 for treatment of neuropathic pain in patients with advanced cancer. KRN5500

Targacept, a biopharmaceutical company, has reported preliminary results showing that AZD3480 met the primary outcome measure in a Phase II clinical study in adults with attention deficit hyperactivity

St Jude Medical, a medical device company, has announced the European CE Mark approval and first use of its EnSite Velocity cardiac mapping system. The EnSite Velocity System

GlaxoSmithKline has received the FDA’s approval for Lamictal ODT orally disintegrating tablets. Lamictal ODT uses a novel drug-delivery formulation to provide Lamictal in a tablet that has a

Swiss healthcare company Cardiola has received CE Mark recertification to market its m.pulse system for at-home use to treat chronic heart failure. Cardiola’s m.pulse system, based on Muscular

Acucela, a biotechnology company, has reported new safety, tolerability and effectiveness data on ACU-4429, an investigational therapy for dry age-related macular degeneration. According to Acucela, study participants tolerated

GlaxoSmithKline has agreed to extend its strategic relationship with Aspen Pharmacare Holdings and to acquire a 16% shareholding in the South African based pharmaceutical company. This is part

MedApps, a provider of mobile wireless health monitoring systems, has formed a partnership with Microsoft to provide a new system to transmit medical device readings into an online health